PRESS RELEASE: In our new report 'Out of Step' MSF has highlighted critical gaps in care for drug resistant tuberculosis (DR-TB) which is fuelling a worldwide public health crisis.

After a two year treatment Gibson Chijaka from Zimbabwe won the battle against DR-TB but lost two years of school life because of his medication.

After two years of treatment that included daily injections and nauseating pills, MSF has helped Gibson Chijaka overcome drug resistant tuberculosis.

Forced quarantine of asymptomatic health workers returning from fighting the Ebola outbreak in West Africa is not grounded on scientific evidence and could undermine efforts to curb the epidemic at its source.

Donka Ebola treatment centre in Conakry, Guinea.

PRESS RELEASE: MSF confirmed today that one of its international staff members who recently returned from Guinea has tested positive for Ebola haemorrhagic fever.

Kailahun Ebola Sierra Leone 2014

We have put in place stringent protocols to protect our staff from exposure to the Ebola virus and to monitor the health of returning staff. Read more about the protocols here.

Kollie James in Foya is the 1000st Ebola survivor

Amidst all the loss and suffering, there are several stories of survival. Today, out of all the patients cared for in MSF’s projects in Guinea, Sierra Leone and Liberia, we celebrate the one thousandth survivor.

Silje contracted Ebola while working for MSF in Sierra Leone. She began to show symptoms on 4th October and was flown home to Norway. Today, she was discharged after recovering from the virus.

1
2
3
4
5
6
7

This month we look at the response to the Ebola outbreak, the escape of our colleague in the Democratic Republic of Congo, the aftermath of the conflict in Gaza, and at the psychological and physical well being of refugees in Ethiopia and Uganda and those from Syria.

PRESS RELEASE: Withthe Ebola epidemic raging, getting Malaria treament has become almost impossible. In response MSF is distributing antimalarials to 300,000 people living in Monrovia’s poorest neighborhoods.

MSF work with other NGOs in southern Niger to prevent Cholera through education about water and sanitation.

Our teams are working to contain a Cholera outbreak in southern Niger after a number of cases were identified last month.

PK5 Muslim neighborhood of Bangui

Nineteen people, including three Médecins Sans Frontières/Doctors Without Borders (MSF) staff, were killed during an armed robbery in the grounds of our hospital in the northern town of Boguila, Central African Republic (CAR) in April this year.

This month we look at healthcare in the time of Ebola in Liberia, the 'Invisible wounds' of mental health and MSF attending to the many people in Iraq that are displaced but still in danger. We also take a look at a new preventive strategy for malnutrition and ask what are the solutions to antibiotic resistance?

MSF decentralisation team. Rural area in Tsholotsho district.

We take a look at a simple and inexpensive treatments initiative, which aims to improve HIV patients' access to care in rural Zimbabwe.

MSF has taken the very difficult decision to temporarily suspend medical activities at Gondama Referral Centre, near Bo, because of the strain the current response to the Ebola outbreak in West Africa has put on the organisation’s capacity in the country.

MSF HOSPITAL, IDLIB Region, SYRIA

Since 4th October, bombing and shelling has intensified in the Erbin area near Damascus. The worst individual incident was the bombing of a market on 9th October which reported a mass-casualty influx of 250 wounded.

Salome Karwah is an Ebola survivor. After recovering from the virus she came back to work at the MSF treatment centre where she fought the disease. This is her story.

PK5 Muslim neighborhood of Bangui

The situation in Bangui, the capital of Central African Republic, has been extremely tense since a wave of violence broke out on 7th October.

PAYNESVILLE, LIBERIA - OCTOBER 05

Dr Bertrand Draguez is Médecins Sans Frontières/Doctors Without Borders (MSF)’s medical director currently working on the West Africa Ebola outbreak. Here he explains why developing vaccines and treatments for Ebola is important, what is needed in order for them to make an impact in this outbreak, and why MSF is taking exceptional measures in facilitating clinical trials for potential treatments.